Everyone is talking about this FDA peptide update But almost no one is explaining it correctly. So let's break it down In 2023, many peptides were placed into Category 2 Kidney Hypoxia, Attributable to Increased Oxygen Consumption, Induces Nephropathy Independently of Hyperglycemia and Oxidative Stress Hypertension Hypoxia and chronic kidney disease eBioMedicine Lithium Induced Renal Dysfunction: Pathophysiology and Clinical Implications